A comparative analysis of tuberculosis in vitro screening in pemphigus patients selected for treatment with rituximab

INTRODUCTION: Patients qualified for the Polish government programme of treating severe pemphigus diseases with rituximab (RTX) available in 2018-2019 had to meet numerous criteria, including no active infectious disease. AIM: The clinical usefulness of tuberculosis screening with the QuantiFERON-TB...

Descripción completa

Detalles Bibliográficos
Autores principales: Jałowska, Magdalena, Gornowicz-Porowska, Justyna, Seraszek-Jaros, Agnieszka, Kaczmarek, Elżbieta, Bowszyc-Dmochowska, Monika, Bartkiewicz, Paweł, Dmochowski, Marian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501442/
https://www.ncbi.nlm.nih.gov/pubmed/34658703
http://dx.doi.org/10.5114/ada.2021.108904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501442/
https://www.ncbi.nlm.nih.gov/pubmed/34658703
http://dx.doi.org/10.5114/ada.2021.108904

Ejemplares similares